- Modern Meadow, a Nutley, New Jersey and Brooklyn, New York based biofabrication company, raised $130m in in Series C funding
- The round was led by Key Partners Capital with participation from Astanor Ventures, Horizons Ventures and Cape Capital
- The company intends to use the funds to invest in research and development across material science and biotechnology
- Modern Meadow is a company that uses biofabrication to create sustainable materials
- Its proprietary technology integrates design, biology, and material science
- The company has a team of 90 people with expertise in molecular biology, material science, engineering, and design
